Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Lamblin

Showing results (31-40 of 163) with videos related to

Pageof 17
Sort By:
International Journal of Cardiology|November 9, 2025
Cardiogenic shock: Who benefits from heart replacement therapy?Miloud Cherbi, François Roubille, Nicolas Lamblin, et al.
Archives of Cardiovascular Diseases|December 5, 2017
Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impactChristophe Bauters, Olivier Tricot, Gilles Lemesle, et al.
European Stroke Journal|April 23, 2019
Incidence and determinants of cerebrovascular events in outpatients with stable coronary artery diseaseCharlotte Cordonnier, Gilles Lemesle, Barbara Casolla, et al.
Circulation. Heart Failure|February 25, 2014
Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after β-blocker therapyPascal de Groote, Marie Fertin, Anju Duva Pentiah, et al.
BMC Infectious Diseases|February 23, 2018
Outcome and prognostic factors of patients with right-sided infective endocarditis requiring intensive care unit admissionHugues Georges, Olivier Leroy, Norair Airapetian, et al.
Archives of Cardiovascular Diseases|September 5, 2016
Effect of left ventricular systolic dysfunction on secondary medical prevention and clinical outcome in stable coronary artery disease patientsNicolas Lamblin, Thibaud Meurice, Olivier Tricot, et al.
European Journal of Heart Failure|March 12, 2004
Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failurePascal de Groote, Nicole Helbecque, Nicolas Lamblin, et al.
European Heart Journal|September 27, 2005
High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failureNicolas Lamblin, Frédéric Mouquet, Bernadette Hennache, et al.
ESC Heart Failure|February 21, 2017
Subacute right heart failure revealing three simultaneous causes of post-embolic pulmonary hypertension in metastatic dissemination of breast cancerFlavien Vincent, Nicolas Lamblin, Marion Classe, et al.
Cardiovascular Diabetology|January 31, 2003
Influence of diabetes mellitus on heart failure risk and outcomeChristophe Bauters, Nicolas Lamblin, Eugène P Mc Fadden, et al.
Pageof 17

Showing results (31-40 of 163) with videos related to

Sort By:
Pageof 17
International Journal of Cardiology|November 9, 2025
Cardiogenic shock: Who benefits from heart replacement therapy?Miloud Cherbi, François Roubille, Nicolas Lamblin, et al.
Archives of Cardiovascular Diseases|December 5, 2017
Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impactChristophe Bauters, Olivier Tricot, Gilles Lemesle, et al.
European Stroke Journal|April 23, 2019
Incidence and determinants of cerebrovascular events in outpatients with stable coronary artery diseaseCharlotte Cordonnier, Gilles Lemesle, Barbara Casolla, et al.
Circulation. Heart Failure|February 25, 2014
Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after β-blocker therapyPascal de Groote, Marie Fertin, Anju Duva Pentiah, et al.
BMC Infectious Diseases|February 23, 2018
Outcome and prognostic factors of patients with right-sided infective endocarditis requiring intensive care unit admissionHugues Georges, Olivier Leroy, Norair Airapetian, et al.
Archives of Cardiovascular Diseases|September 5, 2016
Effect of left ventricular systolic dysfunction on secondary medical prevention and clinical outcome in stable coronary artery disease patientsNicolas Lamblin, Thibaud Meurice, Olivier Tricot, et al.
European Journal of Heart Failure|March 12, 2004
Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failurePascal de Groote, Nicole Helbecque, Nicolas Lamblin, et al.
European Heart Journal|September 27, 2005
High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failureNicolas Lamblin, Frédéric Mouquet, Bernadette Hennache, et al.
ESC Heart Failure|February 21, 2017
Subacute right heart failure revealing three simultaneous causes of post-embolic pulmonary hypertension in metastatic dissemination of breast cancerFlavien Vincent, Nicolas Lamblin, Marion Classe, et al.
Cardiovascular Diabetology|January 31, 2003
Influence of diabetes mellitus on heart failure risk and outcomeChristophe Bauters, Nicolas Lamblin, Eugène P Mc Fadden, et al.
Pageof 17